Market News
Stay updated with the latest market trends, earnings, and economic indicators.

ICICI Prudential Mutual Fund raises stake in Travel Food Services, shares rise
ICICI Prudential Mutual Fund has announced the acquisition of an additional stake in Travel Food Services, increasing its total shareholding in the company to above 5%.

SEBI proposes review of AMC executive remuneration disclosure norms
SEBI seeks public comments on proposed changes to AMC executive pay disclosures, aiming to streamline norms while preserving transparency for mutual fund investments.

Axis MF's Shreyash Devalkar sees opportunities in EVs, exports and FMCG recovery
Shreyash Devalkar, Head of Equity at Axis Mutual Fund, highlighted rising electric vehicle adoption in two-wheelers and said manufacturing exporters could emerge as beneficiaries of rupee depreciation over time. Devalkar also remains selective on consumption plays and cautious on large-cap IT stocks due to weak growth visibility.

Gold ETFs Break 13-Month Win Streak As Investors Pull Out Rs 725 Crore In May
Net gold ETF outflows stood at Rs 725 crore, according to data released by the Association of Mutual Funds in India
India equity mutual fund inflows slip to one-year low in May amid Iran war jitters, AMFI data - Reuters
India equity mutual fund inflows slip to one-year low in May amid Iran war jitters, AMFI dataReuters

Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By Reuters - Investing.com
Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By ReutersInvesting.com
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Should You Own More Gold? Experts Weigh In After ETF Restrictions Across Mutual Funds
Both advisors argued that the discussion should not be limited to gold. Instead, it should prompt investors to think more broadly about diversification.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.